Merck Sharp & Dohme Europe Belgium SRL
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 07 May 2026 | Chiara Galiffa Cabinet member | Latest developments in EU-US relations | SRC |
| 18 Mar 2026 | Pim Lescrauwaet Cabinet member | Policy priorities for Europe's life sciences ecosystem | SRC |
| 18 Mar 2026 | Pim Lescrauwaet Cabinet member | Policy priorities for Europe's life sciences ecosystem | — |
| 11 Mar 2026 | Lucia Granelli Head of Unit | Customs Duty Challenge for New Veterinary Product | SRC |
| 11 Mar 2026 | Lucia Granelli Head of Unit | Customs Duty Challenge for New Veterinary Product | — |
| 03 Feb 2026 | Carmen Laplaza Santos Head of Unit | Exchange of views on the competitiveness of the European pharmaceutical sector. | SRC |
| 03 Feb 2026 | Carmen Laplaza Santos Head of Unit | Exchange of views on the competitiveness of the European pharmaceutical sector. | — |
| 27 Jan 2026 | Peter Sandler Director | Director P. Sandler met with representatives of pharmaceutical company MSD. The discussion focused on economic security aspects, resilience of EU supply chains and pharma sector regulatory developments. | SRC |
| 27 Jan 2026 | Peter Sandler Director | Director P. Sandler met with representatives of pharmaceutical company MSD. The discussion focused on economic security aspects, resilience of EU supply chains and pharma sector regulatory developments. | — |
| 12 Nov 2025 | Flavio Facioni Cabinet member | Inclusion of veterinary aspects in the upcoming proposals of Biotech Act and Food and Feed Safety Simplification | SRC |
| 12 Nov 2025 | Olivér Várhelyi Commissioner | Inclusion of veterinary aspects in the upcoming proposals of Biotech Act and Food and Feed Safety Simplification | SRC |
| 12 Nov 2025 | Olivér Várhelyi Commissioner | Inclusion of veterinary aspects in the upcoming proposals of Biotech Act and Food and Feed Safety Simplification | — |
| 04 Nov 2025 | Olivér Várhelyi Commissioner | Access to medicines | — |
| 04 Nov 2025 | Laszlo Kristoffy Cabinet member | Access to medicines | SRC |
| 04 Nov 2025 | Olivér Várhelyi Commissioner | Access to medicines | SRC |
| 16 Oct 2025 | Laszlo Kristoffy Cabinet member | Biotech Act | SRC |
| 16 Oct 2025 | Laszlo Kristoffy Cabinet member | Biotech Act | — |
| 03 Oct 2025 | Olga Solomon Head of Unit | The discussion focused on simplifying Annex II to foster innovation while aligning with ICH guidelines, with ideas for legacy products to gradually transition. | — |
| 03 Oct 2025 | Olga Solomon Head of Unit | The discussion focused on simplifying Annex II to foster innovation while aligning with ICH guidelines, with ideas for legacy products to gradually transition. | SRC |
| 02 Oct 2025 | Olivér Várhelyi Commissioner | All pressing portfolio topics | SRC |
| 02 Oct 2025 | Jana Dabbelt Cabinet member | All pressing portfolio topics | SRC |
| 02 Oct 2025 | Jana Dabbelt Cabinet member | All pressing portfolio topics | — |
| 18 Sept 2025 | Laszlo Kristoffy Cabinet member | Taking stock of transatlantic trade relations in the field of pharmaceuticals | — |
| 18 Sept 2025 | Laszlo Kristoffy Cabinet member | Taking stock of transatlantic trade relations in the field of pharmaceuticals | SRC |
| 04 Sept 2025 | Laszlo Kristoffy Cabinet member | Taking stock of pharma affairs and current EU-US relations | SRC |
Mission & Goals
MSD is a global healthcare leader who is working to help the world be well. Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching programmes that donate and deliver our products to the people who need them. . For more information, visit www.msd.com.
EU Legislative Interests
EU initiatives pertaining to pharmaceutical policy, industrial policy, health policy (both human and animal) and trade policy, eg, Clinical Trials Regulation, Data Protection Regulation, Public Procurement Directive, Joint Action on Chronic diseases, European Active & Health Ageing Partnership, Crossborder Healthcare Directive, and Falsified Medicines Directive.
Communication Activities
Working actively with several industry associations, eg. EFPIA, EUCOPE, EuropaBio, EAPM. Organizing events on industrial and health policy. Engaging with EU policy makers in EU institutions. Working actively with other health policy stakeholders.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
MSD is a member of , EFPIA, VE, EuropaBio, AmCham EU, Friends of Europe, EURORDIS, EAPM (European Alliance for personalised Medicine), CER (Centre for European Reform), EPC (European Policy Council), AECA (The American European Community Association), ACEBA (American-Central European Business Association), Digital Europe, British Chamber of Commerce, Kangoroo Group, European Food Forum, European Risk and Innovation Forum, AnimalhealthEurope, European Forum of Farm Animal Breeders, EPAA (European Partnership for Alternative Approaches to Animal Testing), Lung Cancer Policy Network, Allied for Startups, All.Can International, EUCOPE, Farm Europe
Organisation Members
N/A
Additional Information
The amount declared in answer includes: relevant percentage of trade associations' work and consultants as declared
Connected Legislation